Keywords: AstraZeneca, Nexium patent, EPO, Teva, Crestor, Brilinta

AstraZeneca looses out on European Nexium-related patent decision; downgraded by BarCap

Article | 13 June 2011

Print This

The European Patent Office has invalidated one of the patents - EP1020461 - on Anglo-Swedish drug major AstraZeneca’s ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in